IMMIX BIOPHARMA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.115 USD | -2.53% |
|
-1.41% | -69.65% |
| Apr. 29 | Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment | MT |
| Apr. 18 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 2.640 | 3.700 | 7.270 |
| Spread/Res. | -20.45% | -43.24% | -71.11% |
| Spread/Supp. | +0.00% | +0.00% | +21.39% |
| Support | 2.100 | 2.100 | 1.730 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IMMX Stock
- Charts Immix Biopharma, Inc.
